October 2008

 

Issue

Supplement

CHIEF MEDICAL EDITOR'S PAGE

Exploring Options in the SFA

By John R. Laird, Jr, MD, Chief Medical Editor

TECHNIQUES

Remote Endarterectomy

This minimally invasive procedure is a viable treatment option for many patients with peripheral vascular disease.

By David Rosenthal, MD; Eric D. Wellons, MD; Allison B. Burkett, MD; and Paul V. Kochupura, MD

COVER STORY

Excisional Atherectomy: Workhorse or Niche?

Where does excisional atherectomy work best for lower extremity arterial occlusive disease?

By Michael C. Nguyen, MD, and Lawrence A. Garcia, MD

Scoring and Cutting Balloons for SFA Disease Treatment

The role of these devices for percutaneous intervention in this challenging anatomy.

By Marc Bosiers, MD; Koen Deloose, MD; Jurgen Verbist, MD; and Patrick Peeters, MD

Covered Stents for the Treatment of SFA Occlusive Disease

A case-based discussion of stent graft use in this challenging anatomy.

By Subhash Banerjee, MD; Emmanouil S. Brilakis, MD, PhD; and Tony S. Das, MD

Drug-Coated Balloons

Paclitaxel-coated balloons show promise as a treatment option for intravascular interventions.

By Gunnar Tepe, MD, and Ulrich Speck, Phd

Practical Uses of Cryoplasty

A look at some of the effective applications of this nonsurgical treatment option.

By Pranab Das, MD; Santosh K. Koshy, MD; Robert S. Dieter, MD, RVT; and Aravinda Nanjundappa, MD, RVT

Lessons Learned in RESILIENT

Co-Principal Investigator John R. Laird Jr, MD, discusses the results and impact of this landmark SFA stenting trial.

The Zilver PTX Global Registry and RCT

Michael D. Dake, MD, discusses the early experiences in the Zilver PTX randomized trial and the results seen in the larger global registry studying a paclitaxel-eluting stent in the SFA.

The DURABILITY II Trial

Krishna Rocha-Singh, MD, FACC, FSCAI, discusses the current status of the DURABILITY II trial, a challenging landmark study of patency and fracture resistance of stenting in the superficial femoral and popliteal arteries.

CODING & REIMBURSEMENT

CMS Withdraws CCI Policy Change

The Correct Coding Initiative policy decision is good news for endovascular physicians.

By Jackie Miller, RHIA, CPC

An Interview with Jos C. van den Berg, MD, PhD

A leading interventional radiologist discusses vascular closure, differences between CE Mark and FDA approval, and highlights of his current research.

By Jos C. van den Berg, MD, PhD
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.